- Home
- EBS vs EFR Comparison
EBS vs EFR Comparison
Compare EBS & EFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- EFR
- Stock Information
- Founded
- EBS 1998
- EFR 2003
- Country
- EBS United States
- EFR United States
- Employees
- EBS N/A
- EFR N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- EFR Trusts Except Educational Religious and Charitable
- Sector
- EBS Health Care
- EFR Finance
- Exchange
- EBS Nasdaq
- EFR Nasdaq
- Market Cap
- EBS 359.3M
- EFR 348.5M
- IPO Year
- EBS 2006
- EFR N/A
- Fundamental
- Price
- EBS $7.16
- EFR $11.91
- Analyst Decision
- EBS Strong Buy
- EFR
- Analyst Count
- EBS 3
- EFR 0
- Target Price
- EBS $14.33
- EFR N/A
- AVG Volume (30 Days)
- EBS 1.4M
- EFR 88.6K
- Earning Date
- EBS 08-06-2025
- EFR 01-01-0001
- Dividend Yield
- EBS N/A
- EFR 9.43%
- EPS Growth
- EBS N/A
- EFR N/A
- EPS
- EBS N/A
- EFR 1.69
- Revenue
- EBS $965,400,000.00
- EFR N/A
- Revenue This Year
- EBS N/A
- EFR N/A
- Revenue Next Year
- EBS $16.15
- EFR N/A
- P/E Ratio
- EBS N/A
- EFR $7.74
- Revenue Growth
- EBS N/A
- EFR N/A
- 52 Week Low
- EBS $4.02
- EFR $10.95
- 52 Week High
- EBS $15.10
- EFR $13.29
- Technical
- Relative Strength Index (RSI)
- EBS 53.48
- EFR 42.60
- Support Level
- EBS $6.89
- EFR $11.89
- Resistance Level
- EBS $7.83
- EFR $12.15
- Average True Range (ATR)
- EBS 0.37
- EFR 0.09
- MACD
- EBS -0.00
- EFR -0.03
- Stochastic Oscillator
- EBS 42.80
- EFR 11.76
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.